Retirement Group’s GSK GSK Stock Holding History

Retirement Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$1.72K	Hold	40	–	–	﹤0.01%	671
2023 Q4	$1.48K	Hold	40	–	–	﹤0.01%	666
2023 Q3	$1.45K	Hold	40	–	–	﹤0.01%	612
2023 Q2	$1.43K	Sell	40 -243	-86%	-$8.72K	﹤0.01%	644
2023 Q1	$10K	Buy	283 +40	+16%	+$1.4K	﹤0.01%	393
2022 Q4	$9K	Hold	243	–	–	﹤0.01%	362
2022 Q3	$7K	Sell	243 -400	-62%	-$15.2K	0.01%	294
2022 Q2	$15K	Hold	643	–	–	0.01%	372
2022 Q1	$18K	Hold	643	–	–	0.01%	358
2021 Q4	$20K	Hold	643	–	–	0.01%	335
2021 Q3	$24K	Buy	643 +400	+165%	+$20.1K	0.01%	286
2021 Q2	$12K	Hold	243	–	–	0.01%	386
2021 Q1	$11K	Buy	243 +3	+1%	+$136	0.01%	457
2020 Q4	$11K	Sell	240 -520	-68%	-$23.9K	0.01%	419
2020 Q3	$36K	Buy	760 +240	+46%	+$12K	0.02%	278
2020 Q2	$27K	Buy	+520	New	+$26.7K	0.02%	291
2019 Q4	$31K	Buy	+520	New	+$28.9K	0.02%	271

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Retirement Group's GSK Position: Q1 2024 in Review

Retirement Group held its GSK (GSK) position steady in Q1 2024 at 40 shares worth $1.72K. The position accounts for ﹤0.01% of the portfolio, ranked #671.

Retirement Group first reported a position in GSK in Q4 2019 and has held it in 17 quarters since. The position peaked at $36K in Q3 2020. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

Retirement Group held 40 shares of GSK worth $1.72K as of Q1 2024.
Retirement Group left its GSK share count unchanged in Q1 2024.
GSK made up ﹤0.01% of Retirement Group's portfolio in Q1 2024, its #671 holding.
Retirement Group first reported a position in GSK in Q4 2019 and has held it in 17 quarters since.
Retirement Group's GSK position peaked at $36K in Q3 2020.
910 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on Retirement Group's 13F filing for Q1 2024, filed 30 Apr 2024.